The latest research from Fore Pharma, Global Smoking Cessation Clinical Trial Pipeline Highlights – 2020, provides most up-to-date information on key pipeline products in the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this research helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Research Scope:
– Products by Clinical Trial Stages: Smoking Cessation pipeline products by clinical trial stages including both early and late stage development – phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
– Drug Mechanism Classes: Smoking Cessation pipeline products by their dominant mechanism of action / drug class. This helps executives categorize products based on their drug class.
– Company: Smoking Cessation pipeline products by developing company.
– Short-term Launch Highlights: Find out which Smoking Cessation pipeline products will be launched in the US and Ex-US till 2025.
Summary of Contents:
– Smoking Cessation phase 3 clinical trial pipeline products
– Smoking Cessation phase 2 clinical trial pipeline products
– Smoking Cessation phase 1 clinical trial pipeline products
– Smoking Cessation preclinical research pipeline products
– Smoking Cessation discovery stage pipeline products
– Smoking Cessation pipeline products short-term launch highlights
Table of Contents
1. Smoking Cessation Pipeline by Stages
2. Smoking Cessation Phase 3 Clinical Trial Insights
3. Smoking Cessation Phase 2 Clinical Trial Insights
4. Smoking Cessation Phase 1 Clinical Trial Insights
5. Smoking Cessation Preclinical Research Insights
6. Smoking Cessation Discovery Stage Insights
7. Appendix
8. Research Methodology
List of Tables
Table 1: Smoking Cessation Phase 3 Clinical Trials, 2020
Table 2: Smoking Cessation Phase 2 Clinical Trials, 2020
Table 3: Smoking Cessation Phase 1 Clinical Trials, 2020
Table 4: Smoking Cessation Preclinical Research, 2020
Table 5: Smoking Cessation Discovery Stage, 2020
List of Figures
Figure 1: Smoking Cessation Pipeline Molecules by Clinical Trials Stage, 2020
Figure 2: Smoking Cessation Phase 3 Clinical Trial Highlights, 2020
Figure 3: Smoking Cessation Phase 2 Clinical Trial Highlights, 2020
Figure 4: Smoking Cessation Phase 1 Clinical Trial Highlights, 2020
Figure 5: Smoking Cessation Preclinical Research Highlights, 2020
Figure 6: Smoking Cessation Discovery Stage Highlights, 2020
Format
Default dispatch format is PDF.